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An Adherent Cell Perifusion Technique
to Study the Overall and Sequential
Response of Rat Alveolar Macrophages
to Toxic Substances
by Gilles Forget,* Marie-Jose Lacroix,* Alain Cadieux,*
Raymond Calvert,* John H. Grosetand Pierre Sirois*
Essentially pure (97%) alveolar macrophages were isolated by bronchoalveolar lavage of rats with
warm (370C) PBS solution. These cells were allowed to adhere to the inside walls of open-ended glass
cylinders which were closed off at each end by three-way stopcocks. The adhering cells were perifused
with RPMI-1640 medium supplemented with 5% fetal bovine serum for 18 hr at the rate of 1 mL/hr,
and the effluent medium was collected automatically in 2-mL aliquots. Cell recoveries and viabilities
did not differ from those found for Petri cultures treated similarly, indicating that the perifusion
method under study offered an adequate milieu for short-term primary cultures. The alveolar macro-
phages in culture were subjected to the presence of particulate (chrysotile asbestos) and soluble (phor-
bol myristate) toxicants, and their response was monitored in the effluent medium by measuring the
release of prostaglandins (PGE) by radioimmunoassay. A significant increase in the sequential re-
lease of PGE was observed in the presence of asbestos (100Mg/mL) or phorbol myristate (200 ng/mb).
Treatment of the cells with indomethacin (20 MM) completely abolished the release of PGE stimu-
lated with phorbol myristate. A cumulative response to the toxicants was also observed when cells
were harvested manually from the chambers: asbestos caused a 2-fold increase in cell mortality rela-
tive to control, while phorbol myristate brought about a 3-fold increase in the number of dead cells.
This effect was not prevented by the presence of indomethacin. Cell aggregation was also observed
when cells were perifused in the presence of phorbol myristate, whether indomethacin was present
or absent. Our results indicate that the cell perifusion system combines the advantages of conven-
tional adherent cell cultures (viability, aggregation) with those of perifusion techniques (sequen-
tial metabolism studies.
Introduction
Alveolar macrophages participate in the initial de-
fense mechanism ofthe lower respiratory airways to
particulate materials (1-3). Through phagocytosis,
they ingest and remove from alveoli and terminal
bronchioli, foreign and endogenous particulate bod-
ies. In this way, they maintain the integrity of the
bronchoalveolar milieu. They also take part in the
initiation of the inflammatory response to toxic air-
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borne irritants. This they accomplish through the re-
lease of several mediators of inflammation, for in-
stance, prostaglandins, lysosomal enzymes and mon-
okines (4-7). Until now, conventional cultures ofalve-
olar macrophages have been used to assess the cum-
ulative release of these mediators. More recently,
different techniques which permitthe culture ofvari-
ous cell types with continuously renewable media
have appeared in the literature (8-13). These novel
methods make possible a sequentialanalysis ofsecre-
tion products as the culture progresses. However,
most of them do not permit a total recovery of cells
at the end of the experiment for the purpose of
assessing the viability of the perifused cell popula-
tion. The method described here combines the ad-
vantages of perifusion techniques with those of con-
ventional adherent cell cultures. It has been used toFORGETETAL.
study the effect of both particulate and soluble cyto-
toxic compounds on rat alveolar macrophages.
Methods and Materials
Isolation of Rat Alveolar Macrophages
All glassware and plasticware used in these expe-
riments were siliconized and sterilized prior to use.
One rat was rendered unconscious by the intraperi-
toneal administration of 0.8 mL Nembutal (20% Ab-
bott). The abdominal cavity was cut open, and the
animal was exsanguinated by sectioning the dorsal
aorta and portal vein. The diaphragm was breached
to prevent efficient respiratory movements, and the
rib cage was cut open along the sternal cartilage.
The trachea was denuded and cannulated with a
flanged catheter which was tied firmly into place.
The other end of the catheter was joined by a three-
way stopcock (model K75, Pharmaseal) to a pair of
20-mL syringes. Eight equal volumes (10 mL) of
warm (370C) sterile phosphate-buffered saline (PBS)
solution were injected into the lungs by one syringe
and aspirated in the other after gentle massage of
the lungs essentially as described for the guinea pig
by Maxwell et al. (14). The lavage fluid was com-
bined and kept on ice until centrifuged at 350g for
10 min. Pellets which contained blood, as evidenced
by gross discoloration, were discarded, and the
lavage-procedure was repeated on another animal.
The pellets were resuspended in a combined volume
of sterile PBS solution and recentrifuged at 350g for
10 min after the determination of cell number and
assessment of cell viability by the trypan blue ex-
clusion method. The pellet was resuspended in a
volume of RPMI-1640 medium containing l-gluta-
mine (Gibco or Flow Laboratories) and an antibiot
ic/antimycotic solution (penicillin, 1000 U/mL,
streptomycin, 1000 ,ug/mL, and Fungizone, 0.25
,ug/mL, Gibco) to yield a final concentration of 10
million cells/mL. Differential cell counts were
performed after cytocentrifugation and staining by
a combination of Wright and Giemsa stains. Cell
pellets containing approximately 106 cells were also
processed for electron microscopy after fixation in
1% glutaraldehyde and postfixation in osmium
tetroxide.
Perifusion of Alveolar Macrophages
The perifusion chamber consisted of an open-
ended glass tube (tubing inserts from Corbeil Tissue
Culture System, Bellco Glass) measuring 135 mm-in
length with an inside diameter of 5.5 mm. Each end
was occluded by a three-way stopcock (model K75,
Pharmaseal) fitted with a piece of Silastic tubing
(0.104 in. inside diameter, 0.192 in. outside diameter)
over the narrow port to tighten the fit. The efferent
end of the chamber was fitted with a piece of nylon
filter (Nytex 1 ,um pore size, B. & S. H. Thompson) by-
tween tube and stopcock(Fig. 1).
FIGURE 1. Perifusion chamber: (A) unassembled chamber showing (3WS) three-way stopcock; (ST) Silastic tubing; (NF) Nytex fil-
ter; (TI) tubing insert from Corbeil Tissue Culture system; (B) assembled chamber with (TT) Teflon tape.
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Alveolar macrophages (AM) were diluted to 106
cells/mL in RPMI-1640 medium containing 20% fetal
bovine serum (Gibco or Flow Laboratories), and 3 mL
of this suspension were introduced in the perifusion
chamber through the afferent stopcock. The cham-
ber inlet and outlet were closed off, and the cham-
bers were incubated for 1 hr at 37°C to allow the ad-
herence of AM to the glass. At the end ofthe incuba-
tion period the fluid was aspirated through the entry
port and replaced with an equal volume of fresh
RPMI-1640 medium supplemented with 5% fetal bo-
vine serum. The inflow stopcock was connected to a
50 mL syringe containing the same serum-supple-
mented medium through a sterile Twin Site Veno-
tube 81 cm IV extension with two "Y" injection sites
(Abbott). The effluent stopcock was connected to the
needle adapter of a venotube extension fitted with a
50 cm length of Intramedic polyethylene tubing (1.7
mm diameter). The assembly was kept at 370C and
perfused with the medium contained in the syringe
by a syringe pump (Valey Scientific Co., Model 540
DD) at the rate of 1 mL/hr. The effluent medium
was collected automatically in 2 mL aliquots for 18
hr. At the end of the experiment, the cells were
harvested by gently scraping the inside walls of the
perifusion chambers with a glass rod fitted with a
piece of Silastic tubing. The cells were counted, and
the viability of the population was evaluated by the
trypan blue exclusion method. In a number of expe-
riments, alveolar macrophages were also cultured
for 18 hr in a Falcon Petri dish (60 mm diameter) in
an incubator so that viabilities and cell retentions
could be compared. In certain instances, cells re-
covered from the chambers were pelleted and pro-
cessed for electron microscopy.
Canadian chrysotile B asbestos (UICC classifica-
tion) was sterilized and suspended in RPMI-1640 me-
dium containing 5% fetal bovine serum in a glass
Dounce type homogenizer and introduced by the
free port of the afferent stopcock in a 3 mL total
volume. Soluble compounds to be tested were dis-
solved in the serum-supplemented (5%) medium
contained in the 50 mL reservoir syringe.
Radioimmunoassay of Prostaglandins E
The measurement of prostaglandin E2 was per-
formed by radioimmunoassay. The final reaction
mixture was 470 ML distributed as follows: 3001.L so-
dium borate buffer (50 mM, pH 8.0) containing 0.1%
boviney-globulin(Sigma), 10IML(3C)PGE2(5nCi, New
England Nuclear), 100 ML sample and 60ML antibody
diluted 1:100 (final dilution 1:780). The reaction was
allowed to proceed at 40C for either 3 or 18 hr. Free
radioactive PGE2 was precipitated out with the addi-
tion of 200 ,L of dextran-coated charcoal (5 mg Dex-
tran T-70, 250 mg Norit-A in 20 mL borate buffer).
After 15 min at4°C, the preparation was centrifuged
in an IEC microfuge(International Centrifuge, Model
MB) for 1 min, and 400 ML of the supernatant were
mixed with 8 mL of either Bray's scintillation cock-
tail or Solution-947 (New England Nuclear) for evalu-
ation of the radioactivity by scintillation spectrom-
etry in a LKB-Wallach Rack-Beta scintillation coun-
ter. Standards of 10 to 500 pg were used in the stan-
dard curve of the assay, and the curve was linear in
respect to a logit/log scales graph. All curve fitting
and calculations were done on a Radio Shack Model
III microcomputer with a program developed in the
author's laboratory. The antibody was produced as
described previously (15). The reactivity of the anti-
body to other prostaglandins and arachidonic acid
metabolites was negligible. The only exception was
the high cross reactivity with PGE,, and for this rea-
son, the results obtained were assigned to PGE ac-
tivity instead ofPGE,.
Statistics
Results are expressed as the mean + SEM of a
minimum offive observations. The significance ofob-
served differences was tested by the Student's t-
test for either paired variables or for two means as
the case warranted, as stipulated in the text. The re-
sults were considered significant at the 0.05 or 0.01
levels ofconfidence.
Results
Evaluation of the Perifusion Method with
Respect to Cell Viability
The mean number of free alveolar cells obtained
per rat was 1.52 ± 0.8 x 107 cells (mean + SEM,N =
28). Preparations containing more than 18 million
cells were considered atypical and discarded. Viabili-
ties exceeded 85% in all preparations with a mean of
90.1% ± 0.6. Differential cell counts performed after
cytocentrifugation indicated a consistently high alve-
olar macrophage count (97%) in contrast to contami-
nantcells (lymphocytes, 2%; pneumoctyes, < 1%).
The perifusion culture method was compared to a
conventional static Petri culture. The Falcon plastic
Petri dish had a bottom surface of28.3 cm2compared
to a total internal surface of 23.3 cm2 for the perifu-
sion chamber. However, microscopic observation of
the perifusion chamber disclosed that the AM were
mainly adhered to the bottom half of the available
surface. Notwithstanding this, the perifusion cham-
bers retained by adherence as many cells as the
Petri dishes. After 18 hr,there was nosignificant dif-
ference between the number ofcells retained by the
perifusion chambers and those harvested from the
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Petri dishes, indicating that cells did not migrate out
of the chamber during perifusion (Table 1). Cell via-
bility was also compared for the two methods and
was not found todiffer significantly (Table 1).
Chambers containing AM were perifused in the
presence of either dialyzed (Gibco) or undialyzed
(Flow Laboratories) fetal bovine serum (5%). A sta-
tistical evaluation of cell viabilities under those two
conditions revealed that the undialyzed serum was
significantly more efficient in preserving cell viabil-
ity thanthe dialyzed serum(Table 1).
Electron microscopic observation ofthe cell prepa-
rations before and after an 18-hr perifusion were in-
dicative of ultrastructural integrity (Figs. 2 and 3).
The surface of the AM obtained immediately after
bronchoalveolar lavage is covered with numerous
pseudopodia,and this feature is alsoapparent in cells
which have been perifused for 18 hr. The cytoplasm
of the fresh cells contains the normal complement of
organelles with a prominence of primary and sec-
ondary lysosomes. Residual bodies are also common.
The Golgi apparatus is well developed, and the cyto-
plasm contains elongated mitochrondria and large
clear vacuoles. A small number ofgranular endoplas-
mic reticulum cisternae are present, together with
polyribosomes and freeribosomes.
AM which have been perifused for 18 hr appear
normal, as they do not differ from the preceding
cells. The nucleus is normal, and the cytoplasm con-
tains a very large number of primary and secondary
lysosomes, together with many residual bodies. The
mitochrondria appear normal in all respects, as does
the Golgi complex. There seems to be a larger com-
plement of granular endoplasmic reticulum cister-
nae, and clear vacuoles are scarce and reduced in
size. In general, the electron microscopic appearance
ofthe cells which have been perifused for 18 hr is not
significantly different morphologically from freshly
obtained cells.
Table 1. Comparison of cell culture parameters and methods
Culture Retention (18 hr), Mortality, %
method mean ± SEM N)a mean ± SEM ()
Plastic Petri dish 1.24 ± 0.06 x 106 16.6 ± 1.5 (6)
(60 mm diameter) cells (7)
Perifusion chamber 1.17 ± 0.04 x 106 17.1 ± 1.7 (6) N.S.C
cells (6) N.S.b
Perifusion chamber (5% dialyzed 22.9 ± 0.6 (6)
serum)
Perifusion chamber (5% undialyzed 14.5 ± 1.2 (24),
serum) p <O.Olb
aThe original inoculate was 3 x 106 cells in all cases. After
1 hr preincubation, medium and nonadherent cells were re-
moved and new medium introduced.
bt test for individual means performed on actual cell counts.
et test for paired values (performed on the actual cell
counts).
Effect of Particulate and Soluble Toxicants
on Perifused AM
The sequential liberation of PGE was assessed
with respect to soluble and particulate toxicants. Ca-
nadian chrysotile B was introduced in a perifusion
chamber (100 ,.g/mL) which has perifused for 18 hr
against a control chamber containing serum-supple-
mented medium only. As illustrated in Figure 4, as-
bestos stimulated the metabolism ofarachidonic acid
in rat AM. Prostaglandins E levels, which averaged
less than 1 ng/2 hr in untreated perifused cells, in-
creased progressively during the first 6 hr of peri-
fusion in fiber treated cells and maintained a pla-
teau of approximately 1.8 ng/million cells/2 hr of in-
cubation. The increase observed in the presence of
asbestos was significant between 10 and 16 hr of
perifusion. The cytotoxicity of the asbestos fibers
was indicated by a significantly higher mortality in
that chamber (44%) against that of the control
chamber (21.9%) (p < 0.01).
Phorbol myristate is a membrane-active com-
pound which has been shown to stimulate the release
of prostaglandins from macrophages in vitro (16) and
was tested in the present system (200 ng/mL). In
order to verify specificity ofthe PGE release, a third
chamber containing phorbol myristate and in-
domethacin (20 MM was run in parallel to the
control and phorbol myristate (Fig. 5). The synthesis
of PGE stimulated by this agent increases rapidly
and steadily during the first 8 hr, after which it
slowly diminishes, although it remains much higher
than in control cells throughout the whole period.
However, the presence of indomethacin, an inhibitor
of cyclooxygenase (17), in the perifusion medium,
nullifies the phorbol myristate-induced release of
PGE in a significant fashion.
The viability of AM is strongly diminished by
phorbol myristate both in the presence (33.9%) or in
the absence ofindomethacin (32.9%) in respect tothe
control chamber (10.4%)(p <0.01). Phorbol myristate
also produced cell aggregation, another effect which
was not inhibited by indomethacin. This observation
was obtained at the end of the perifusion experi-
ments, when the harvested cells were counted and
their viability evaluated. In both cases, the aggrega-
tion was marked (79% and 80.1%), while it was very
low in the control chambers (9%). These results are
tabulated in Table 2.
Electron microscopy of cells perifused in the pres-
ence of phorbol myristate (Fig. 6) shows cells which
are strikingly different from fresh or control peri-
fused cells. The moststriking feature is the modifica-
tion in a large number ofcells ofthe surface pattern.
The thin pseudopodia have been replaced by numer-
ous blebs all around the periphery of the macro-
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phage. The nucleus is normal. The cytoplasm has a
disorganized appearance; it contains fewer lyso-
somes and residual bodies. Occasional lipid droplets
can be seen and the cristae are abnormal in many mi-
tochrondria.
Discussion
One problem encountered with conventional cell
cultures is the ever-present possibility that accumu-
lating metabolites and/or secretory products can in-
FIGURE 2. Freshly isolated rat alveolar macrophage (original magnification 6703x): (N) nucleus; (L) lysosome; (G) Golgi complex;
(R) granular endoplasmic reticulum; (P) phagosome; (p) pseudopod; (M) mitochondrion; (V) vacuoles.
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fluence the outcome of the experiment through posi-
tive or negative feedback. Several methods have
been proposed in recent years to overcome this by
maintaining cell cultures in a flow of continuously re-
newed medium. This has generally been accom-
plished along two main lines. Either the cells are su-
perfused in a column containing a support (8, 18) or
they are perifused in a chamber on filters (9-13). The
purpose ofthe present study was to design a cell cul-
ture system which combined the advantages of both
FIGURE 3. Rat alveolar macrophage after 18 hr perifusion in serum supplemented (5%) RPMI-1640 medium (original magnifica-
tion 17,806 x ): (N) nucleus; (L) lysosome); (G) golgi complex; (R) granular endoplasmic reticulum; (P) phagosome; (p) pseudopod.
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Table 2. Characteristics of phorbol myristate-induced cell aggregation.
Chamber
Control
Phorbol myristate
Phorbol myristate + indomethacin
Mean number of aggregates (x 103)
2-5 5-10 >10 cells/ Free
cells/aggregate cells/aggregate aggregate cella
33 0 0 954
55 37 28 252
49 36 45 223
aFree nonaggregated cell.
Mean cell total % aggregated
1.18 ± 0.03 x 10' 9
1.22 + 0.02x 106 78.6
1.22 ± 0.04 x 106 80.2
FIGURE 6. Rat alveolar macrophage after 18 hr perifusion in the presence of phorbol myristate (original magnification 11,403 x ):
(N) nucleus; (V) vacuoles; (P) phagosome; (Li) lipid droplets; (B) blebs; (L) lysosome.
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the traditional primary adherent cell culture with
the additional boon of renewed medium and sequen-
tial analysis ofcell output.
Differential cell counting by cytocentrifugation in-
dicates that the relatively simple lavage method
used on the rat lung provides a very homogeneous,
virtually pure alveolar macrophage population. Be-
cause the medium is renewed between the preincu-
bation of cells in the chamber and the actual perifu-
sion experiment, only the adhering and viable cells
are retained in the chamber at the beginning of the
experiment. The present technique is the only peri-
fusion culture technique to date which permits the
elimination ofdead or moribund cells before the peri-
fusion is initiated.
Parallel studies of Petri and perifused cultures in-
dicate that there is no significant migration of AM
from the perifusion chamber. This is no doubt facili-
tated by the filter position at the effluent end of the
chamber and by the relatively low flow rate of peri-
fusion. Moreover, the matching viabilities in both
Petri and perifused cultures strongly suggest that
the perifusion chamber can offer an adequate milieu
on which the AM can thrive just as they are wont to
do in traditional cultures. The adequacy ofthe cham-
bers to maintain viable cells in short- and medium-
term cultures is further emphasized by the normal
aspect of the AM as seen by the electron micro-
scope after 18 hr of perifusion.
The use ofdialyzed serum appears to be less bene-
ficial to the AM than the undialyzed counterpart.
This is reflected by the increased viability concomi-
tant with the use of undialyzed serum. It is of note
that the baseline output ofPGE in control chambers
is lower and more regular with the undialyzed serum
(Fig. 4) than with dialyzed serum (Fig. 3). This points
to the fact that the conditions optimal to well-being
ofthe AM are very sensitive tominor modifications.
The level ofPGE output cannot be lowered signifi-
cantly between baseline levels by the addition of in-
domethacin in the medium, although this potent in-
hibitor of prostaglandin synthesis (17) is capable of
preventing phorbol myristate-stimulated release of
PGE. While this finding is difficult to explain, the
blocking effect of phorbol myristate-mediated re-
lease of PGE is unequivocal, and points to the speci-
ficity of the observed stimulation. This stimulation
has been reported by Chang et al. (16) for traditional
cultures ofmurine peritoneal macrophage. However,
these authors report a plateau in the release ofPGE
after 2 hr, while in the present system,the release of
PGE is linear duringthe first 8 hr followed by a slow
decline, still above control levels during the rest of
the perifusion experiment. These observations could
indicate that a negative feedback mechanism, which
was at work in the murine macrophage monolayer
culture, was circumvented in the perifusion system
because ofmedium replacement.
Asbestos-mediated release of prostaglandins from
macrophage has already been described using adher-
ing macrophage cultures (5, 7, 19, 20). The present
findings confirm these reports. The perifusion
system can thus be used to study inflammatory
responses of AM to either soluble or particulate
toxic substances. Just as important, this technique
allows direct observation of the cells following the
perifusion to assess such criteria as viability and
aggregation. It was thus possible to observe that
apart from causing release of PGE, both asbestos
and phorbol myristate can cause cell death. The two
compounds produced 2- and 3-fold cell mortalities in
the perifused populations, respectively. Interesting-
ly enough, the addition of indomethacin to the
perifusion medium in the presence of phorbol myris-
tate did not prevent mortality. It could thus indi-
cate that PGE synthesis and liberation is not neces-
sarily related to cell death. The aggregation was not
measured in asbestos experiments. The AM were
aggregated onto asbestos fibers, and these pre-
vented precise easy evaluation of the size of aggre-
gates.
The technique presented in this study has permit-
ted the evaluation of several important criteria of in-
flammation and cytotoxicity. It was valuable both
with particulate and soluble compounds. Comparison
with traditional methods of cell cultures indicates
that the perifusion system is just as valid for the pre-
servation of cell viability. It can prove invaluable in
the sequential study of many processes and still al-
low the evaluation of criteria which were until now
not easily quantifiable in the course of the available
perifusion methods.
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